Retention is an earnings lever, not a service metric: a 5% rise in retention lifts profit by 25 to 95%, and acquiring a customer costs 5 to 25x more than keeping one. On an illustrative £70M recurring-revenue base, the contribution-margin at risk is £1.9M to £5.0M annually, of which £1.2M to £3.6M is protectable through churn reduction and renewal discipline. This briefing sets out the seven hypotheses tested by the Accelr8 Retention module, mapping the Customer Retention lever onto the Revenue Quality and Margin Integrity pools.
Signal from the research
Profit from +5% retention
25 to 95%
Profit uplift from a 5-point retention gain (Bain, Reichheld)
Acquire vs retain
5 to 25x
Cost to acquire a new customer vs retain an existing one (Bain)
Sell-success to existing
60 to 70%
Vs 5 to 20% to a new prospect (Bain / Marketing Metrics)
Revenue durability
NRR
Net revenue retention is the single clearest signal of revenue quality
Seven testable hypotheses
| # | Hypothesis | Evidence base | Test during sprint | Recovery | Priority |
|---|---|---|---|---|---|
| R1 | Avoidable Logo Churn | Bain/Reichheld: a 5-point retention gain lifts profit 25 to 95%; much churn is avoidable and predictable. | Model churn by cohort and reason; isolate the avoidable, addressable share | £500K to £1.8M | High |
| R2 | Net Revenue Retention Gap | Contraction outpacing expansion within the base erodes durable revenue and exit value. | Decompose NRR into expansion, contraction and churn by segment | £300K to £900K | High |
| R3 | Passive and Silent Non-renewal | Renewals lapse with no active motion; no owner, no renewal calendar, no early outreach. | Build a renewal calendar from contracts and billing; flag at-risk renewals early | £200K to £600K | Med-High |
| R4 | Discount-to-Retain Leakage | Margin given away to save accounts that were not actually at risk, or beyond what was needed. | Correlate retention discounts with genuine churn risk and outcome | £150K to £450K | Med-High |
| R5 | CAC-to-LTV Imbalance | Bain: acquisition costs 5 to 25x retention; spend skewed to acquiring over keeping. | Compare CAC and LTV by channel and cohort; rebalance toward retention | £150K to £500K | Medium |
| R6 | Early-life and Onboarding Churn | Disproportionate attrition in the first 90 days where value is not realised quickly. | Track activation and first-value milestones against early-life churn | £120K to £400K | Medium |
| R7 | At-risk Early-warning Signals | Usage decline, support load and sentiment predict churn before renewal, but go unmonitored. | Assemble a read-only signal set into an at-risk score in the Trust Ledger | Risk amplifier | Medium |
Composite value at risk, £70M recurring-revenue base
| Hypothesis | Exposed base | Leakage rate | Value at risk | Recovery potential |
|---|---|---|---|---|
| R1 Avoidable Churn | £70M recurring | contrib. margin | £500K to £1.8M | £500K to £1.8M |
| R2 NRR Gap | £70M recurring | 0.4 to 1.3 pts | £300K to £900K | £300K to £900K |
| R3 Silent Non-renewal | £20M renewals | 1 to 3% | £200K to £600K | £200K to £600K |
| R4 Discount-to-Retain | £15M at-risk | 1 to 3% | £150K to £450K | £150K to £450K |
| R5 CAC:LTV | Acquisition spend | Qualitative | £150K to £500K | £150K to £500K |
| R6 Early-life Churn | New cohorts | Qualitative | £120K to £400K | £120K to £400K |
| R7 Early Warning | Cross-cutting | Qualitative | Risk amplifier | Enables R1, R3 |
| Total composite (excluding R7 amplifier) | £1.4M to £4.7M | £1.2M to £3.6M | ||
Durability is valued at exit: retained, expanding revenue is worth a higher multiple than churning revenue. Protecting £1.2M to £3.6M of contribution margin implies £12M to £36M of enterprise value at 10x, before any re-rating for improved revenue quality.
Sources
Bain & Company / Frederick Reichheld retention economics (5% retention to 25 to 95% profit; 5 to 25x acquisition cost). Marketing Metrics sell-success to existing vs new customers. Net-revenue-retention framing per standard SaaS and subscription benchmarks.
Disclaimer: Figures are illustrative for a fictitious mid-market PortCo with ~£70M recurring or renewable revenue and a 10x EBITDA exit multiple, for demonstration only. Retention figures are expressed as contribution-margin impact, not gross revenue. All percentages are published benchmarks from the cited research. The 40-day diagnostic sprint replaces these estimates with measured actuals.